Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Direct In Vivo Human Intestinal Permeability (Peff) Determined with Different Clinical Perfusion and Intubation Methods
David Dahlgren, Carl Roos, Erik Sjögren, et al.
Journal of Pharmaceutical Sciences (2014) Vol. 104, Iss. 9, pp. 2702-2726
Open Access | Times Cited: 112

Showing 26-50 of 112 citing articles:

Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
Yoshinao Tarumi, Yasuhiro HIGASHIGUCHI, Kiyohiko Sugano
Pharmaceutical Research (2025)
Open Access
Small molecule drug absorption in inflammatory bowel disease and current implementation in physiologically- based pharmacokinetic models
Jonas Langeraert, Elke Gasthuys, An Vermeulen
European Journal of Pharmaceutical Sciences (2025), pp. 107095-107095
Open Access
Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling
Aleksandra Vulović, Tijana Šušteršič, Sandra Cvijić, et al.
European Journal of Pharmaceutical Sciences (2017) Vol. 113, pp. 171-184
Closed Access | Times Cited: 38
Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms
David Dahlgren, Carl Roos, Pernilla Johansson, et al.
Molecular Pharmaceutics (2016) Vol. 13, Iss. 9, pp. 3022-3033
Closed Access | Times Cited: 34
Intestinal absorption-modifying excipients: A current update on preclinical in vivo evaluations
David Dahlgren, Markus Sjöblom, Hans Lennernäs
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 411-420
Closed Access | Times Cited: 32
Global Analysis of Models for Predicting Human Absorption: QSAR, In Vitro, and Preclinical Models
Edward Price, J. Cory Kalvass, David A. DeGoey, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 9389-9403
Closed Access | Times Cited: 25
Predicting Oral Absorption for Compounds Outside the Rule of Five Property Space
Felix Huth, Norbert Domange, Birk Poller, et al.
Journal of Pharmaceutical Sciences (2021)
Open Access | Times Cited: 24
Predictions from First-Principles of Membrane Permeability to Small Molecules: How Useful Are They in Practice?
Christophe Chipot
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 15, pp. 4533-4544
Closed Access | Times Cited: 10
Six years of progress in the oral biopharmaceutics area – A summary from the IMI OrBiTo project
Bertil Abrahamsson, Mark McAllister, Patrick Augustijns, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 152, pp. 236-247
Open Access | Times Cited: 25
All layers matter: Innovative three-dimensional epithelium-stroma-endothelium intestinal model for reliable permeability outcomes
Maria Helena Macedo, Andreia S. Barros, Elena Martínez, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 414-430
Closed Access | Times Cited: 22
Oral controlled release dosage forms: dissolution versus diffusion
Marival Bermejo, Bárbara Sánchez-Dengra, Marta González‐Álvarez, et al.
Expert Opinion on Drug Delivery (2020) Vol. 17, Iss. 6, pp. 791-803
Closed Access | Times Cited: 21
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metformin Hydrochloride
Melissa Metry, Yan Shu, Bertil Abrahamsson, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 110, Iss. 4, pp. 1513-1526
Closed Access | Times Cited: 18
Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption
Andrés Olivares‐Morales, Hans Lennernäs, Leon Aarons, et al.
The AAPS Journal (2015) Vol. 17, Iss. 5, pp. 1177-1192
Open Access | Times Cited: 24
Comparison of segmental-dependent permeability in human and in situ perfusion model in rat
Alejandro Ruiz-Picazo, Isabel Lozoya-Agulló, Miguel Ortiz-Azcarate, et al.
European Journal of Pharmaceutical Sciences (2017) Vol. 107, pp. 191-196
Closed Access | Times Cited: 23
Striving Towards the Perfect In Vitro Oral Drug Absorption Model
John P. Gleeson, Fiona McCartney
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 10, pp. 720-724
Closed Access | Times Cited: 22
In vitro–In vivo Relationship and Bioequivalence Prediction for Modified-Release Capsules Based on a PBPK Absorption Model
Rebeka Jereb, Opara Jerneja, Legen Igor, et al.
AAPS PharmSciTech (2019) Vol. 21, Iss. 1
Closed Access | Times Cited: 22
Rat intestinal drug permeability: A status report and summary of repeated determinations
Ilse R. Dubbelboer, David Dahlgren, Erik Sjögren, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 364-376
Closed Access | Times Cited: 20
In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions
Michael Hofmann, Mauricio A. García, Jozef Al-Gousous, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 149, pp. 229-237
Closed Access | Times Cited: 19
Biopharmaceutical characterization of rebamipide: The role of mucus binding in regional-dependent intestinal permeability
Milica Marković, Moran Zur, Arik Dahan, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 152, pp. 105440-105440
Closed Access | Times Cited: 19
Impact of the Unstirred Water Layer on the Permeation of Small-Molecule Drugs
Christopher H. Kang, Alyson Shoji, Christophe Chipot, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 3, pp. 933-943
Closed Access | Times Cited: 2
Formulation strategies to improve the bioavailability of poorly absorbed drugs
Francisco J. Otero‐Espinar, Carlos Bendicho Lavilla, Guillermo Blanco Fernández, et al.
Elsevier eBooks (2024), pp. 223-255
Closed Access | Times Cited: 2
Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects
Xin Luo, Zexin Zhang, Ruijing Mu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 234-234
Open Access | Times Cited: 2
Human enteroid monolayers as a potential alternative for Ussing chamber and Caco-2 monolayers to study passive permeability and drug efflux
Eva J. Streekstra, Marit Keuper-Navis, Jeroen J. M. W. van den Heuvel, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 201, pp. 106877-106877
Open Access | Times Cited: 2
Using the refined Developability Classification System (rDCS) to guide the design of oral formulations
Kristian Beran, Eline Hermans, René Holm, et al.
Journal of Pharmaceutical Sciences (2024)
Open Access | Times Cited: 2
Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability
Katharina F. Hermann, Claudia S. Neuhaus, Virgine Micallef, et al.
European Journal of Pharmaceutical Sciences (2017) Vol. 104, pp. 150-161
Closed Access | Times Cited: 20

Scroll to top